Breast Cancer Coverage from Every Angle
Advertisement
Advertisement

Ongoing CE Activities

36th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series
A Multidisciplinary Approach to Individualized Patient Care-Breast Cancer
Adipose Fat Distribution a CVD Risk After Breast Cancer
Breast Cancer: Genetic Testing and Management
Breast Cancer Prevention, Screening, Diagnosis, and Treatment
Breast Cancer Update, Issue 3, 2019: ER-Positive Edition
Breast Cancer Update: Triple-Negative Edition
Bridging the Gap between Research and Patient Care
Cancer Summaries and Commentaries™: Update from Barcelona: Advances in the Treatment of Breast Cancer
Challenges With the 8th Edition of the AJCC Staging Manual - Staging of Breast Cancer
Changing Landscape of Treatment of HR+ and HER2- Metastatic Breast Cancer with PI3K and CDK 4/6 Inhibitors
Community Practice Connections™: 1st Annual Precision Medicine Symposium: An Illustrated Tumor Board
Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™
Community Practice Connections™: Curbing the Opioid Epidemic: Taking Steps to Improve Postsurgical Outcomes for Your Patients With Breast Cancer
Community Practice Connections™: The Latest Advances on PI3K Inhibition in Breast Cancer: What You Need to Know
Current and Future Directions in PARP Inhibition
Data + Perspectives: Clinical Investigators Explore the Current and Future Management of Triple-Negative Breast Cancer
Elevated Breast Cancer Risk With HRT Persists
Emerging Considerations in Triple-Negative Breast Cancer: Focus on Immunotherapy
Empowering Oncology Teams to Improve Care Quality for Women with Advanced or Metastatic HR+/HER2- Breast Cancer
ER-Negative/PR-Positive Breast Cancer: Real or Artifact?
Evidence-based Integrative Therapies in Breast Cancer
Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of Treatments
Genetic/Familial High-Risk Evaluation in Patients With Breast Cancer
Herceptin: 6 or 12 Months?
HR+/HER2-Negative Breast Cancer: Revolutions in Precision Medicine with PI3K Inhibitors
Implementation and Implications of AJCC Cancer Staging Manual, 8th Edition for Breast Cancer Staging
Improving Outcomes in HER2+ Early Breast Cancer
Improving Outcomes in HER2+ Breast Cancer: Analysis and Application of Evolving Data and Best Practices
Interactive Tumor Panel: Clinical Investigators Discuss Emerging Research and Actual Cases of Patients with Breast Cancer
Locoregional Treatment of Breast Cancer Including SABCS Updates
Management of Lymphedema After Breast Cancer Treatment
Community Practice Connections™: Meeting Key Unmet Clinical Needs in HER2-Positive Breast Cancer: Aligning the Data with Strategy to Improve Patient Outcomes
NCCN GUIDELINES® UPDATES: Breast Cancer- Multigene Testing in Breast Cancer
NCCN 2020 Congress Series: Breast Cancer With Updates From 2019 San Antonio Breast Cancer Symposium
NCCN Guidelines Update: Treatment of Hormone-Sensitive Advanced Breast Cancer
NCCN Harmonized Guidelines for Sub-Saharan Africa
Neoadjuvant & Adjuvant Therapies for Early Stage Breast Cancer
New and Emerging Treatment Options for Refractory HER2+ Metastatic Breast Cancer
New Systemic Therapies for Metastatic Breast Cancer Including SABCS Updates
PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application & Genetic Testing
Prioritizing Women With Dense Breasts for Supplemental Imaging
Proceedings from the First Annual Oncology Nursing Retreat ER-Positive Metastatic Breast Cancer
Proceedings from the First Annual Oncology Nursing Retreat HER2-Positive and Triple-Negative BC
Proton-Beam RT Proves Safe, Effective in Breast Cancer
Rapid Reviews in Oncology® from Chicago: Practice-Changing Data in Breast Cancer
Real-World Strategies to Transform a Triple-Negative Breast Cancer Diagnosis Into Positive Patient Outcomes
Recognition and Intervention for Women With Fluid That Develops Around Breast Implants
NCCN Updates in the treatment of HER-2 Positive Breast Cancer
Enduring CME Activity: School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
Should a Patient with a 2 cm HER2+/TNBC Clinically Node Negative Receive Neoadjuvant Therapy?
The Jackson Laboratory Genetic Testing for Breast Cancer
The New Backbone of Treatment for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer - Animated Whiteboard View
The Role of Lifestyle and the Environment in Breast Cancer Risk
TNBC: Improvements Gained With PD-1/L1 Inhibitors
Use of Genomic Classifiers to Inform Clinical Decision-Making for Patients with Early Breast Cancer
Utility of MultiGene Assays in Management of Early Stage Breast Cancer
When Should Women With a Family History of Breast Cancer Start Screening?


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.